156 related articles for article (PubMed ID: 32386990)
1. Telomerase reactivation is associated with hepatobiliary and pancreatic cancers.
Sansone V; Le Grazie M; Roselli J; Polvani S; Galli A; Tovoli F; Tarocchi M
Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):420-428. PubMed ID: 32386990
[TBL] [Abstract][Full Text] [Related]
2. Telomeres and telomerase: a dual role in hepatocarcinogenesis.
Satyanarayana A; Manns MP; Rudolph KL
Hepatology; 2004 Aug; 40(2):276-83. PubMed ID: 15368430
[TBL] [Abstract][Full Text] [Related]
3. Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers.
Itoi T; Shinohara Y; Takeda K; Nakamura K; Shimizu M; Ohyashiki K; Hisatomi H; Nakano H; Moriyasu F
Int J Mol Med; 2001 Mar; 7(3):281-7. PubMed ID: 11179508
[TBL] [Abstract][Full Text] [Related]
4. Detection of hTERT mRNA in gastrointestinal tract cancer specimens.
Udomchaiprasertkul W; Narong S; Kongsema M; Leelawat K
Southeast Asian J Trop Med Public Health; 2008 Mar; 39(2):324-7. PubMed ID: 18564721
[TBL] [Abstract][Full Text] [Related]
5. DNA Methylation Profiling of hTERT Gene Alongside with the Telomere Performance in Gastric Adenocarcinoma.
Vahidi S; Norollahi SE; Agah S; Samadani AA
J Gastrointest Cancer; 2020 Sep; 51(3):788-799. PubMed ID: 32617831
[TBL] [Abstract][Full Text] [Related]
6. "OMICS" technologies and their role in foregut primary malignancies.
Farid SG; Morris-Stiff G
Curr Probl Surg; 2015 Oct; 52(10):409-41. PubMed ID: 26527526
[No Abstract] [Full Text] [Related]
7. The role of telomeres and telomerase in cirrhosis and liver cancer.
Nault JC; Ningarhari M; Rebouissou S; Zucman-Rossi J
Nat Rev Gastroenterol Hepatol; 2019 Sep; 16(9):544-558. PubMed ID: 31253940
[TBL] [Abstract][Full Text] [Related]
8. Genetic diagnostic test of hepatocellular carcinoma by telomerase catalytic subunit mRNA.
Wada E; Hisatomi H; Moritoyo T; Kanamaru T; Hikiji K
Oncol Rep; 1998; 5(6):1407-12. PubMed ID: 9769378
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
[TBL] [Abstract][Full Text] [Related]
10. High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis.
Oh BK; Kim H; Park YN; Yoo JE; Choi J; Kim KS; Lee JJ; Park C
Lab Invest; 2008 Feb; 88(2):144-52. PubMed ID: 18158557
[TBL] [Abstract][Full Text] [Related]
11. Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma.
Nagao K; Tomimatsu M; Endo H; Hisatomi H; Hikiji K
J Gastroenterol; 1999 Feb; 34(1):83-7. PubMed ID: 10204615
[TBL] [Abstract][Full Text] [Related]
12. Shortened telomere length and increased telomerase activity in hamster pancreatic duct adenocarcinomas and cell lines.
Kobitsu K; Tsutsumi M; Tsujiuchi T; Suzuki F; Kido A; Okajima E; Fukuda T; Sakaki T; Konishi Y
Mol Carcinog; 1997 Mar; 18(3):153-9. PubMed ID: 9115585
[TBL] [Abstract][Full Text] [Related]
13. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
Miura N; Horikawa I; Nishimoto A; Ohmura H; Ito H; Hirohashi S; Shay JW; Oshimura M
Cancer Genet Cytogenet; 1997 Jan; 93(1):56-62. PubMed ID: 9062581
[TBL] [Abstract][Full Text] [Related]
14. Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
Donaires FS; Scatena NF; Alves-Paiva RM; Podlevsky JD; Logeswaran D; Santana BA; Teixeira AC; Chen JJ; Calado RT; Martinelli ALC
PLoS One; 2017; 12(8):e0183287. PubMed ID: 28813500
[TBL] [Abstract][Full Text] [Related]
15. Telomeres, telomerase, and telomerase inhibition: clinical implications for cancer.
Ahmed A; Tollefsbol T
J Am Geriatr Soc; 2003 Jan; 51(1):116-22. PubMed ID: 12534855
[TBL] [Abstract][Full Text] [Related]
16. Telomeres, telomerase and HCC: the long and the short of it.
Erlitzki R; Minuk GY
J Hepatol; 1999 Nov; 31(5):939-45. PubMed ID: 10580594
[No Abstract] [Full Text] [Related]
17. Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma.
Lechel A; Manns MP; Rudolph KL
J Hepatol; 2004 Sep; 41(3):491-7. PubMed ID: 15336455
[No Abstract] [Full Text] [Related]
18. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
19. Telomere length variation in tumor cells and cancer-associated fibroblasts: potential biomarker for hepatocellular carcinoma.
Ma LJ; Wang XY; Duan M; Liu LZ; Shi JY; Dong LQ; Yang LX; Wang ZC; Ding ZB; Ke AW; Cao Y; Zhang XM; Zhou J; Fan J; Gao Q
J Pathol; 2017 Dec; 243(4):407-417. PubMed ID: 28833123
[TBL] [Abstract][Full Text] [Related]
20. Identifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms.
Jiang W; Ding Y; Shen Y; Fan L; Zhou L; Li Z; Zheng Y; Zhao P; Liu L; Tong Z; Fang W; Wang W
Oncotarget; 2017 Jan; 8(3):5016-5025. PubMed ID: 28008139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
